Research Fellows
Susan Bullman, PhD
Postdoctoral Fellow
2014-
PhD, Cork Institute of Technology & Cork University Hospital
My work in the lab relates to host-pathogen interactions, in particular focusing on microorganisms that may contribute to the development of cancer. Microbial pathogens that are capable of inducing invasive cancers are obvious targets for cancer risk assessment, early detection, prevention and targeted treatment. My research aim is to decipher the virulence mechanisms of particular cancer promoting organisms, in order to provide novel therapeutic avenues for treatment.
"Science is a way of thinking much more than it is a body of knowledge."
Carl Sagan
LinkedIn: https://www.linkedin.com/pub/susan-bullman
617-632-4777
Email Dr. Bullman
Postdoctoral Fellow
2014-
PhD, Cork Institute of Technology & Cork University Hospital
My work in the lab relates to host-pathogen interactions, in particular focusing on microorganisms that may contribute to the development of cancer. Microbial pathogens that are capable of inducing invasive cancers are obvious targets for cancer risk assessment, early detection, prevention and targeted treatment. My research aim is to decipher the virulence mechanisms of particular cancer promoting organisms, in order to provide novel therapeutic avenues for treatment.
"Science is a way of thinking much more than it is a body of knowledge."
Carl Sagan
LinkedIn: https://www.linkedin.com/pub/susan-bullman
617-632-4777
Email Dr. Bullman
Jian Carrot-Zhang, PhD
Postdoctoral Fellow
2016-
PhD, McGill University
I use computational approaches to understand the contribution of germline variation to population-specific risk of somatic EGFR mutation in lung adenocarcinoma. I am also interested in studying adaptive resistance to immunotherapy.
"大道至简: the greatest truths are the simplest." -- I Ching
LinkedIn: https://www.linkedin.com/in/jian-carrot-zhang
617-632-2930
Email Dr. Carrot-Zhang
Postdoctoral Fellow
2016-
PhD, McGill University
I use computational approaches to understand the contribution of germline variation to population-specific risk of somatic EGFR mutation in lung adenocarcinoma. I am also interested in studying adaptive resistance to immunotherapy.
"大道至简: the greatest truths are the simplest." -- I Ching
LinkedIn: https://www.linkedin.com/in/jian-carrot-zhang
617-632-2930
Email Dr. Carrot-Zhang
Peter Choi, PhD
Postdoctoral Fellow
2012-
PhD, Stanford University School of Medicine
I am interested in how mutations in splicing regulatory factors and changes in alternative splicing contribute to tumorigenesis. I am also interested in how novel chromosomal rearrangements are involved in driving cancer.
"Life is tough, but you have to enjoy!" - Wenchu Lin
LinkedIn: https://www.linkedin.com/in/petershchoi
617-632-2930
Email Dr. Choi
Postdoctoral Fellow
2012-
PhD, Stanford University School of Medicine
I am interested in how mutations in splicing regulatory factors and changes in alternative splicing contribute to tumorigenesis. I am also interested in how novel chromosomal rearrangements are involved in driving cancer.
"Life is tough, but you have to enjoy!" - Wenchu Lin
LinkedIn: https://www.linkedin.com/in/petershchoi
617-632-2930
Email Dr. Choi
Hugh S. Gannon, PhD
Postdoctoral Fellow
2012-
PhD, University of Massachusetts Medical School
My research focuses on identifying underlying vulnerabilities that arise in the absence of p53 function in cancer. I am also interested in using functional datasets to identify coding and noncoding mutations that increase sensitivity to specific therapeutic treatments.
“Knowledge of Nature is an account at bank, where each dividend is added to the principal and the interest is ever compounded; and hence it is that human progress, founded on natural knowledge, advances with ever increasing speed.” - G.K. Gilbert
LinkedIn: http://www.linkedin.com/pub/hugh-gannon
617-632-4777
Email Dr. Gannon
Postdoctoral Fellow
2012-
PhD, University of Massachusetts Medical School
My research focuses on identifying underlying vulnerabilities that arise in the absence of p53 function in cancer. I am also interested in using functional datasets to identify coding and noncoding mutations that increase sensitivity to specific therapeutic treatments.
“Knowledge of Nature is an account at bank, where each dividend is added to the principal and the interest is ever compounded; and hence it is that human progress, founded on natural knowledge, advances with ever increasing speed.” - G.K. Gilbert
LinkedIn: http://www.linkedin.com/pub/hugh-gannon
617-632-4777
Email Dr. Gannon
Gavin Ha, PhD
Postdoctoral Fellow
2014-
PhD, University of British Columbia
I am interested in applying computational approaches to analyze tumour heterogeneity and to study clonal evolution in cancer. To address these research problems, I develop and apply statistical approaches to analyze data from whole genome and single-cell sequencing of tumour DNA. My goal is to better characterize genomic clonal diversity and understand its implications to cancer progression and therapeutic resistance.
617-714-7495
Email Dr. Ha
Postdoctoral Fellow
2014-
PhD, University of British Columbia
I am interested in applying computational approaches to analyze tumour heterogeneity and to study clonal evolution in cancer. To address these research problems, I develop and apply statistical approaches to analyze data from whole genome and single-cell sequencing of tumour DNA. My goal is to better characterize genomic clonal diversity and understand its implications to cancer progression and therapeutic resistance.
617-714-7495
Email Dr. Ha
Mark Lee, MD, PhD
Postdoctoral Fellow
2014-
MD, PhD, Harvard Medical School
I am interested in discovering pathogens in clinical samples using next-generation sequencing, and applying experimental, high-throughput functional approaches to this problem.
617-714-7258
Email Dr. Lee
Postdoctoral Fellow
2014-
MD, PhD, Harvard Medical School
I am interested in discovering pathogens in clinical samples using next-generation sequencing, and applying experimental, high-throughput functional approaches to this problem.
617-714-7258
Email Dr. Lee
Yoichiro Mitsuishi, MD, PhD
Postdoctoral Fellow
2014-
MD, PhD, Tohoku University
I’m very interested in applying a combination of molecular biology and computational approaches to find unknown basis of lung cancer. I would like to contribute to developing better and more personalized therapies to treat cancer patients.
617- 714-7690
Email Dr. Mitsuishi
Postdoctoral Fellow
2014-
MD, PhD, Tohoku University
I’m very interested in applying a combination of molecular biology and computational approaches to find unknown basis of lung cancer. I would like to contribute to developing better and more personalized therapies to treat cancer patients.
617- 714-7690
Email Dr. Mitsuishi
Alison Taylor, PhD
Postdoctoral Fellow
2013-
PhD, Harvard Medical School
Cancer cells usually have an incorrect number of chromosomes, including loss and gain of chromosome arms. These copy number changes are thought to contribute to tumor development, but the direct effects are unknown. My goal is to develop new methods to model these abnormalities.
"The meeting of two personalities is like the contact of two chemical substances: if there is any reaction, both are transformed." - Carl Jung
LinkedIn: https://www.linkedin.com/in/alisonmtaylor
617-632-2930
Email Dr. Taylor
Postdoctoral Fellow
2013-
PhD, Harvard Medical School
Cancer cells usually have an incorrect number of chromosomes, including loss and gain of chromosome arms. These copy number changes are thought to contribute to tumor development, but the direct effects are unknown. My goal is to develop new methods to model these abnormalities.
"The meeting of two personalities is like the contact of two chemical substances: if there is any reaction, both are transformed." - Carl Jung
LinkedIn: https://www.linkedin.com/in/alisonmtaylor
617-632-2930
Email Dr. Taylor
Srinivas Viswanathan, MD, PhD
Clinical Fellow
2015-
MD, PhD, Harvard Medical School
I am interested in studying the mechanisms underlying splicing aberrancies in hematologic malignancies.
"They are ill discoverers that think there is no land, when they can see nothing but sea." - Francis Bacon
617-632-3779
Email Dr. Viswanathan
Clinical Fellow
2015-
MD, PhD, Harvard Medical School
I am interested in studying the mechanisms underlying splicing aberrancies in hematologic malignancies.
"They are ill discoverers that think there is no land, when they can see nothing but sea." - Francis Bacon
617-632-3779
Email Dr. Viswanathan
Doug Wheeler, MD, PhD
Postdoctoral Fellow
2015-
PhD, Memorial Sloan-Kettering Cancer Center
I am interested in identifying genes that are altered in cancer that have not yet been previously identified as involved in tumorigenesis. I would like to use in vivo screening approaches in mice to find lung cancer genes that can drive tumor formation in the physiological context of the lung.
"Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less." -Marie Curie
617-714-7838
Email Dr. Wheeler
Postdoctoral Fellow
2015-
PhD, Memorial Sloan-Kettering Cancer Center
I am interested in identifying genes that are altered in cancer that have not yet been previously identified as involved in tumorigenesis. I would like to use in vivo screening approaches in mice to find lung cancer genes that can drive tumor formation in the physiological context of the lung.
"Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less." -Marie Curie
617-714-7838
Email Dr. Wheeler
Xiaoyang Zhang, PhD
Postdoctoral Fellow
2013-
PhD, Dartmouth College
I am interested in integrating cancer genomics, epigenomics and genome-editing methods to study 1) the biological function of cancer genomic alterations occurring in non-coding regions and 2) how mutations in epigenetic regulators and transcription factors drive tumorigenesis.
617-714-8688
Email Dr. Zhang
Postdoctoral Fellow
2013-
PhD, Dartmouth College
I am interested in integrating cancer genomics, epigenomics and genome-editing methods to study 1) the biological function of cancer genomic alterations occurring in non-coding regions and 2) how mutations in epigenetic regulators and transcription factors drive tumorigenesis.
617-714-8688
Email Dr. Zhang